Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -11,783 | -9,806 | -11,489 | -9,003 |
| Depreciation Amortization | 953 | 250 | 47 | 36 |
| Income taxes - deferred | 13 | -115 | N/A | N/A |
| Other Working Capital | -523 | 2,112 | 151 | -142 |
| Other Operating Activity | -945 | 212 | 6,043 | 6,303 |
| Operating Cash Flow | $-12,285 | $-7,347 | $-5,248 | $-2,806 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 3,733 | 1,185 | -15,494 | N/A |
| PPE Investments | -1,118 | -2,808 | -199 | -2 |
| Purchase Of Investment | N/A | N/A | -72 | -19 |
| Sale Of Investment | -125 | 9,949 | -10,104 | N/A |
| Other Investing Activity | -99 | -313 | -366 | -141 |
| Investing Cash Flow | $2,391 | $8,013 | $-26,235 | $-162 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | N/A | N/A | 2,275 |
| Common Stock Issued | 2 | 33 | 46,306 | N/A |
| Common Stock Repurchased | -77 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 3,761 | 4,692 |
| Financing Cash Flow | $-75 | $33 | $50,067 | $6,967 |
| Exchange Rate Effect | -26 | -62 | -3 | N/A |
| Beginning Cash Position | 23,345 | 22,708 | 4,127 | 128 |
| End Cash Position | 13,350 | 23,345 | 22,708 | 4,127 |
| Net Cash Flow | $-9,995 | $637 | $18,581 | $3,999 |
| Free Cash Flow | ||||
| Operating Cash Flow | -12,285 | -7,347 | -5,248 | -2,806 |
| Capital Expenditure | -1,155 | -2,808 | -199 | -2 |
| Free Cash Flow | -13,440 | -10,155 | -5,447 | -2,808 |